Alcidion Group (ASX:ALC) PE Ratio (TTM): 31.67 (As of Jun. 29, 2026) — 68% Below Median


What is Alcidion Group PE Ratio (TTM)?

Alcidion Group ASX:ALC -1.04% PE Ratio (TTM) is 31.67 as of Jun. 29, 2026, which is 68% below its 10-year median of 100.00. The stock has 4 warning signs investors should review. Among 430 Healthcare Providers & Services companies, Alcidion Group ranks worse than 67.67% on this metric.

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-29), Alcidion Group's share price is A$0.095. Alcidion Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Therefore, Alcidion Group's PE Ratio (TTM) for today is 31.67.

Good Sign:

Alcidion Group Ltd stock PE Ratio (=96) is close to 1-year low of 89.


The historical rank and industry rank for Alcidion Group's PE Ratio (TTM) or its related term are showing as below:

ASX:ALC' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 31.67   Med: 100   Max: 125
Current: 31.67


During the past 13 years, the highest PE Ratio (TTM) of Alcidion Group was 125.00. The lowest was 31.67. And the median was 100.00.


ASX:ALC's PE Ratio (TTM) is ranked worse than
67.67% of 430 companies
in the Healthcare Providers & Services industry
Industry Median: 21.585 vs ASX:ALC: 31.67

Alcidion Group's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was A$0.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

As of today (2026-06-29), Alcidion Group's share price is A$0.095. Alcidion Group's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00. Therefore, Alcidion Group's PE Ratio without NRI for today is 31.67.

During the past 13 years, Alcidion Group's highest PE Ratio without NRI was 125.00. The lowest was 31.67. And the median was 100.00.

Alcidion Group's EPS without NRI for the six months ended in Dec. 2025 was A$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

During the past 13 years, Alcidion Group's highest 3-Year average EPS without NRI Growth Rate was 66.90% per year. The lowest was -44.20% per year. And the median was 0.00% per year.

Alcidion Group's EPS (Basic) for the six months ended in Dec. 2025 was A$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.


Alcidion Group  (ASX:ALC) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Alcidion Group PE Ratio (TTM) Related Terms


Alcidion Group PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for Alcidion Group's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcidion Group PE Ratio (TTM) Chart

Alcidion Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 100.00

Alcidion Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss 100.00 At Loss

ASX:ALC vs VEEV, BTSG, TEM: PE Ratio (TTM) Comparison

For the Health Information Services subindustry, Alcidion Group's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcidion Group PE Ratio (TTM) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Alcidion Group's PE Ratio (TTM) falls into.



Alcidion Group PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Alcidion Group's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=0.095/0.003
=31.67

Alcidion Group's Share Price of today is A$0.095.
For company reported semi-annually, Alcidion Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio (TTM) →
What does a PE Ratio (TTM) of 31.67 mean?
Alcidion Group (ASX:ALC) has a PE Ratio (TTM) of 31.67 as of Jun. 29, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Alcidion Group and its competitors. This is 68% below median its historical median of 100.00. Over the past decade, Alcidion Group's PE Ratio (TTM) has ranged from 31.67 to 125.00. According to the industry distribution chart, Alcidion Group ranks #291 out of 430 companies in the Healthcare Providers & Services industry, placing it in the top 67.7%.
Is Alcidion Group's PE Ratio (TTM) too high?
Alcidion Group's current PE Ratio (TTM) of 31.67 is 68% below median its 10-year median of 100.00. Over the past 10 years, this metric has ranged from a low of 31.67 to a high of 125.00. The Healthcare Providers & Services industry median PE Ratio (TTM) is 21.59. Alcidion Group's value of 31.67 is 46.7% above this industry median. Based on the distribution chart, Alcidion Group ranks #291 out of 430 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Alcidion Group's PE Ratio (TTM) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #291 out of 430 companies for PE Ratio (TTM). This places Alcidion Group in the lower half of its industry. The industry median PE Ratio (TTM) is 21.59. Alcidion Group's value of 31.67 is 46.7% above this benchmark. Historically, Alcidion Group's own PE Ratio (TTM) has ranged from 31.67 to 125.00 over the past decade. While the company's 10-year median is 100.00 vs. the industry median of 21.59, Alcidion Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Healthcare Providers & Services company?
The median PE Ratio (TTM) among Healthcare Providers & Services companies is 21.59, based on 430 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current PE Ratio (TTM) of 31.67 is 46.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio (TTM) is 21.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current PE Ratio (TTM) is 31.67, which is 68% below median its own 10-year median of 100.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 20.8% below its estimated fair value. The current PE Ratio (TTM) is 31.67, which is 68% below median its 10-year median of 100.00 and 46.7% above the Healthcare Providers & Services industry median of 21.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current PE Ratio (TTM) is 31.67 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alcidion Group Business Description

Address 9 Yarra Street, Level 10, South Yarra, Melbourne, VIC, AUS, 3141
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.